z-logo
open-access-imgOpen Access
The Changes in the Endothelial Function and Haemostatic and Inflammatory Parameters in Subclinical and Overt Hyperthyroidism
Author(s) -
Anna PopławskaKita,
Katarzyna Siewko,
Beata Telejko,
Anna Modzelewska,
Janusz Myśliwiec,
Robert Milewski,
Maria Górska,
Małgorzata Szelachowska
Publication year - 2013
Publication title -
international journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.875
H-Index - 60
eISSN - 1687-8345
pISSN - 1687-8337
DOI - 10.1155/2013/981638
Subject(s) - medicine , subclinical infection , gastroenterology
. The aim of the present study was to compare the levels of circulating markers of endothelial function and low-grade inflammation in patients with subclinical and overt hyperthyroidism (OH) due to Graves disease (GD) and toxic nodular goiter (TNG). Material and Methods . The group studied consisted of 42 patients with GD, 75 patients with TNG, and 39 healthy controls. Results . Circulating markers of endothelial dysfunction were elevated in the patients with both SH and OH, but the concentrations of interleukin-12 (IL-12) ( P < 0.05), IL-18 ( P < 0.05), fibrinogen ( P < 0.01), and von Willebrand factor (vWF) ( P < 0.05) were significantly higher in the OH than in the SH group. The highest levels of IL-6, IL-12, IL-18, vWF, sVCAM-1, and fibrinogen were found in the patients with GD, but the differences between the GD, and TNG groups were not significant. In the subjects with OH serum IL-6 was positively associated with FT3 ( R = 0.276, P < 0.05), FT4 ( R = 0.273, P < 0.05), and thyroid peroxidase antibodies ( R = 0.346, P < 0.01) levels. Conclusion . Our results may suggest that both SH and OH may be associated with endothelial dysfunction, which is reflected by decreased fibrinolytic activity, hypercoagulability, and increased levels of IL-6, IL-12, and IL-18 and depends not only on the cause but also on the degree of hyperthyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom